speb/financial-data huggingface dataset:
PCVX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 36927000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3071334000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 3071334000.00
PCVX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
PCVX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
PCVX balance_sheet (quarterly, 2025-06-30) — Total Assets: 3305363000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 3071334000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Total Debt: 85845000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3071334000.00
PCVX income_statement (quarterly, 2025-06-30) — Total Expenses: 226219000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 234029000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1589588000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 79543000.00
PCVX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -226219000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Working Capital: 1561289000.00
PCVX income_statement (quarterly, 2025-09-30) — +Operating Expense: 242380000.00
PCVX income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
PCVX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 48962000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 4800333000.00
PCVX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 136196512.00
PCVX income_statement (quarterly, 2025-09-30) — Basic EPS: -1.56
PCVX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 308063000.00
PCVX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -12046000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 84443000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 133000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 281080000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1711320000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 202681000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Cash Financial: 78399000.00
PCVX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -3671000.00
PCVX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 121170000.00
PCVX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -143305000.00
PCVX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 17877000.00
PCVX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 20052000.00
PCVX cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -11316000.00
PCVX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -1401000.00
PCVX cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 5948000.00
PCVX cash_flow (quarterly, 2025-09-30) — Change In Payable: 17877000.00
PCVX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 37929000.00
PCVX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 915000.00
PCVX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 32075000.00
PCVX cash_flow (quarterly, 2025-09-30) — Changes In Cash: -25806000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Common Stock: 133000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2892882000.00
PCVX cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
PCVX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 128551000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Current Assets: 1767167000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 5771000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 5771000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 200046000.00
PCVX cash_flow (quarterly, 2025-09-30) — Depreciation: 5197000.00
PCVX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 5197000.00
PCVX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 5197000.00
PCVX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 136196512.00
PCVX income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.56
PCVX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -212830000.00
PCVX income_statement (quarterly, 2025-09-30) — EBIT: -242380000.00
PCVX income_statement (quarterly, 2025-09-30) — EBITDA: -237183000.00
PCVX cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 291000.00
PCVX cash_flow (quarterly, 2025-09-30) — End Cash Position: 282548000.00
PCVX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -3671000.00
PCVX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -155351000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 856000.00
PCVX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 32447000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 337001000.00
PCVX income_statement (quarterly, 2025-09-30) — Interest Income: 29259000.00
PCVX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 29259000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2892882000.00
PCVX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 121170000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 959256000.00
PCVX cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
PCVX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 78672000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 78672000.00
PCVX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
PCVX cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -789000.00
PCVX income_statement (quarterly, 2025-09-30) — Net Income: -212830000.00
PCVX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -212830000.00
PCVX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -212830000.00
PCVX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -212830000.00
PCVX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -212830000.00
PCVX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -212830000.00
PCVX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -212830000.00
PCVX income_statement (quarterly, 2025-09-30) — Net Interest Income: 29259000.00
PCVX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 133216000.00
PCVX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 29259000.00
PCVX cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -3977000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Net PPE: 337001000.00
PCVX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -12046000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2892882000.00
PCVX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -237183000.00
PCVX income_statement (quarterly, 2025-09-30) — Normalized Income: -212830000.00
PCVX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -143305000.00
PCVX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -789000.00
PCVX income_statement (quarterly, 2025-09-30) — Operating Income: -242380000.00
PCVX income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
PCVX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 130029111.00
PCVX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 55847000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 856000.00
PCVX income_statement (quarterly, 2025-09-30) — Other Gand A: 32447000.00
PCVX income_statement (quarterly, 2025-09-30) — Other Income Expense: 291000.00
PCVX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -2264000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 108176000.00
PCVX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 291000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Other Properties: 337001000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 1430240000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Payables: 48962000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 177513000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 16762000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
PCVX income_statement (quarterly, 2025-09-30) — Pretax Income: -212830000.00
PCVX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 306000.00
PCVX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -255315000.00
PCVX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -12046000.00
PCVX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 5197000.00
PCVX income_statement (quarterly, 2025-09-30) — Research And Development: 209933000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1908440000.00
PCVX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 388531000.00
PCVX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 32447000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Share Issued: 130029111.00
PCVX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 35306000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2892882000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2892882000.00
PCVX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
PCVX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
PCVX balance_sheet (quarterly, 2025-09-30) — Total Assets: 3171600000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2892882000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Total Debt: 84443000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 2892882000.00
PCVX income_statement (quarterly, 2025-09-30) — Total Expenses: 242380000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 278718000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1404433000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 78672000.00
PCVX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -242380000.00
PCVX balance_sheet (quarterly, 2025-09-30) — Working Capital: 1567121000.00
PCVX income_statement (annual, 2025-12-31) — +Operating Expense: 923675000.00
PCVX income_statement (quarterly, 2025-12-31) — +Operating Expense: 274283000.00
PCVX income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
PCVX income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
PCVX balance_sheet (annual, 2025-12-31) — Accounts Payable: 70904000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 70904000.00
PCVX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -32770000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -32770000.00
PCVX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 4838736000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 4838736000.00
PCVX balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 881664000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 881664000.00
PCVX income_statement (annual, 2025-12-31) — Basic Average Shares: 136089506.00
PCVX income_statement (annual, 2025-12-31) — Basic EPS: -5.63
PCVX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 389195000.00
PCVX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 282548000.00
PCVX cash_flow (annual, 2025-12-31) — Capital Expenditure: -56973000.00
PCVX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -8421000.00
PCVX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 117481000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 117481000.00
PCVX balance_sheet (annual, 2025-12-31) — Capital Stock: 134000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 134000.00
PCVX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 173959000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 173959000.00
PCVX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1560959000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1560959000.00
PCVX balance_sheet (annual, 2025-12-31) — Cash Equivalents: 88542000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 88542000.00
PCVX balance_sheet (annual, 2025-12-31) — Cash Financial: 85417000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Cash Financial: 85417000.00
PCVX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2014000.00
PCVX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2408000.00
PCVX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 437354000.00
PCVX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 115125000.00
PCVX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -655577000.00
PCVX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -224832000.00
PCVX cash_flow (annual, 2025-12-31) — Change In Account Payable: 19906000.00
PCVX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 21667000.00
PCVX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 37026000.00
PCVX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -24849000.00
PCVX cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -92257000.00
PCVX cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -46335000.00
PCVX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 46371000.00
PCVX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 33137000.00
PCVX cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 2302000.00
PCVX cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 6226000.00
PCVX cash_flow (annual, 2025-12-31) — Change In Payable: 19906000.00
PCVX cash_flow (quarterly, 2025-12-31) — Change In Payable: 21667000.00
PCVX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 56932000.00
PCVX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -3182000.00
PCVX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -16800000.00
PCVX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -9549000.00
PCVX cash_flow (annual, 2025-12-31) — Change In Working Capital: -3452000.00
PCVX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -19703000.00
PCVX cash_flow (annual, 2025-12-31) — Changes In Cash: -216209000.00
PCVX cash_flow (quarterly, 2025-12-31) — Changes In Cash: -107299000.00
PCVX balance_sheet (annual, 2025-12-31) — Common Stock: 134000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Common Stock: 134000.00
PCVX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2685510000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2685510000.00
PCVX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
PCVX cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
PCVX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 101016000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 101016000.00
PCVX balance_sheet (annual, 2025-12-31) — Current Assets: 1627361000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Current Assets: 1627361000.00
PCVX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 6124000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 6124000.00
PCVX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 6124000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 6124000.00
PCVX balance_sheet (annual, 2025-12-31) — Current Liabilities: 205750000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 205750000.00
PCVX cash_flow (annual, 2025-12-31) — Depreciation: 24860000.00
PCVX cash_flow (quarterly, 2025-12-31) — Depreciation: 9800000.00
PCVX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 24860000.00
PCVX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 9800000.00
PCVX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 24860000.00
PCVX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 9800000.00
PCVX income_statement (annual, 2025-12-31) — Diluted Average Shares: 136089506.00
PCVX income_statement (annual, 2025-12-31) — Diluted EPS: -5.63
PCVX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -766628000.00
PCVX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -246507000.00
PCVX income_statement (annual, 2025-12-31) — EBIT: -923675000.00
PCVX income_statement (quarterly, 2025-12-31) — EBIT: -274283000.00
PCVX income_statement (annual, 2025-12-31) — EBITDA: -898815000.00
PCVX income_statement (quarterly, 2025-12-31) — EBITDA: -264483000.00
PCVX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 2439000.00
PCVX cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 176000.00
PCVX cash_flow (annual, 2025-12-31) — End Cash Position: 175425000.00
PCVX cash_flow (quarterly, 2025-12-31) — End Cash Position: 175425000.00
PCVX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 2014000.00
PCVX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 2408000.00
PCVX cash_flow (annual, 2025-12-31) — Free Cash Flow: -712550000.00
PCVX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -233253000.00
PCVX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1587000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1587000.00
PCVX income_statement (annual, 2025-12-31) — General And Administrative Expense: 129369000.00
PCVX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 32223000.00
PCVX balance_sheet (annual, 2025-12-31) — Gross PPE: 524488000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 524488000.00
PCVX income_statement (annual, 2025-12-31) — Interest Income: 119718000.00
PCVX income_statement (quarterly, 2025-12-31) — Interest Income: 26451000.00
PCVX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 119718000.00
PCVX income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 26451000.00
PCVX balance_sheet (annual, 2025-12-31) — Invested Capital: 2685510000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2685510000.00
PCVX cash_flow (annual, 2025-12-31) — Investing Cash Flow: 437354000.00
PCVX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 115125000.00
PCVX balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 881664000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 881664000.00
PCVX balance_sheet (annual, 2025-12-31) — Investments And Advances: 881664000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 881664000.00
PCVX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
PCVX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
PCVX balance_sheet (annual, 2025-12-31) — Leases: 7239000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Leases: 7239000.00
PCVX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 111357000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 111357000.00
PCVX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 111357000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 111357000.00
PCVX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 338694000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 338694000.00
PCVX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
PCVX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
PCVX cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -34768000.00
PCVX cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -1655000.00
PCVX income_statement (annual, 2025-12-31) — Net Income: -766628000.00
PCVX income_statement (quarterly, 2025-12-31) — Net Income: -246507000.00
PCVX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -766628000.00
PCVX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -246507000.00
PCVX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -766628000.00
PCVX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -246507000.00
PCVX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -766628000.00
PCVX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -246507000.00
PCVX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -766628000.00
PCVX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -246507000.00
PCVX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -766628000.00
PCVX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -246507000.00
PCVX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -766628000.00
PCVX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -246507000.00
PCVX income_statement (annual, 2025-12-31) — Net Interest Income: 119718000.00
PCVX income_statement (quarterly, 2025-12-31) — Net Interest Income: 26451000.00
PCVX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 494327000.00
PCVX cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 123546000.00
PCVX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 119718000.00
PCVX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 26451000.00
PCVX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -10991000.00
PCVX cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1007000.00
PCVX balance_sheet (annual, 2025-12-31) — Net PPE: 491718000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Net PPE: 491718000.00
PCVX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -56973000.00
PCVX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -8421000.00
PCVX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2685510000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2685510000.00
PCVX income_statement (annual, 2025-12-31) — Normalized EBITDA: -898815000.00
PCVX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -264483000.00
PCVX income_statement (annual, 2025-12-31) — Normalized Income: -766628000.00
PCVX income_statement (quarterly, 2025-12-31) — Normalized Income: -246507000.00
PCVX cash_flow (annual, 2025-12-31) — Operating Cash Flow: -655577000.00
PCVX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -224832000.00
PCVX cash_flow (annual, 2025-12-31) — Operating Gains Losses: -34768000.00
PCVX cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -1655000.00
PCVX income_statement (annual, 2025-12-31) — Operating Income: -923675000.00
PCVX income_statement (quarterly, 2025-12-31) — Operating Income: -274283000.00
PCVX income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
PCVX income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
PCVX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 131058858.00
PCVX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 131058858.00
PCVX balance_sheet (annual, 2025-12-31) — Other Current Assets: 66402000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 66402000.00
PCVX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 1587000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 1587000.00
PCVX income_statement (annual, 2025-12-31) — Other Gand A: 129369000.00
PCVX income_statement (quarterly, 2025-12-31) — Other Gand A: 32223000.00
PCVX income_statement (annual, 2025-12-31) — Other Income Expense: 37329000.00
PCVX income_statement (quarterly, 2025-12-31) — Other Income Expense: 1325000.00
PCVX cash_flow (annual, 2025-12-31) — Other Non Cash Items: -14434000.00
PCVX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -2764000.00
PCVX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1974000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1974000.00
PCVX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 100000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 100000.00
PCVX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 37329000.00
PCVX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1325000.00
PCVX balance_sheet (annual, 2025-12-31) — Other Properties: 178555000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Other Properties: 178555000.00
PCVX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 1387000000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 1387000000.00
PCVX balance_sheet (annual, 2025-12-31) — Payables: 75610000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Payables: 75610000.00
PCVX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 176626000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 176626000.00
PCVX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 23000000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 23000000.00
PCVX balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
PCVX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
PCVX income_statement (annual, 2025-12-31) — Pretax Income: -766628000.00
PCVX income_statement (quarterly, 2025-12-31) — Pretax Income: -246507000.00
PCVX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 13005000.00
PCVX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 3415000.00
PCVX balance_sheet (annual, 2025-12-31) — Properties: 0.00
PCVX balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
PCVX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -1211499000.00
PCVX cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -292649000.00
PCVX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -56973000.00
PCVX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -8421000.00
PCVX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 24860000.00
PCVX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 9800000.00
PCVX income_statement (annual, 2025-12-31) — Research And Development: 794306000.00
PCVX income_statement (quarterly, 2025-12-31) — Research And Development: 242060000.00
PCVX income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
PCVX balance_sheet (annual, 2025-12-31) — Retained Earnings: -2154947000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -2154947000.00
PCVX cash_flow (annual, 2025-12-31) — Sale Of Investment: 1705826000.00
PCVX cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 416195000.00
PCVX income_statement (annual, 2025-12-31) — Selling General And Administration: 129369000.00
PCVX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 32223000.00
PCVX balance_sheet (annual, 2025-12-31) — Share Issued: 131058858.00
PCVX balance_sheet (quarterly, 2025-12-31) — Share Issued: 131058858.00
PCVX income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
PCVX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 138845000.00
PCVX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 35997000.00
PCVX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2685510000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2685510000.00
PCVX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2685510000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2685510000.00
PCVX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PCVX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PCVX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
PCVX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
PCVX balance_sheet (annual, 2025-12-31) — Total Assets: 3002717000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Total Assets: 3002717000.00
PCVX balance_sheet (annual, 2025-12-31) — Total Capitalization: 2685510000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 2685510000.00
PCVX balance_sheet (annual, 2025-12-31) — Total Debt: 117481000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Total Debt: 117481000.00
PCVX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2685510000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2685510000.00
PCVX income_statement (annual, 2025-12-31) — Total Expenses: 923675000.00
PCVX income_statement (quarterly, 2025-12-31) — Total Expenses: 274283000.00
PCVX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 317207000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 317207000.00
PCVX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1375356000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1375356000.00
PCVX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 111457000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 111457000.00
PCVX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -923675000.00
PCVX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -274283000.00
PCVX balance_sheet (annual, 2025-12-31) — Total Tax Payable: 4706000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 4706000.00
PCVX income_statement (annual, 2025-12-31) — Total Unusual Items: 0.00
PCVX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
PCVX balance_sheet (annual, 2025-12-31) — Working Capital: 1421611000.00
PCVX balance_sheet (quarterly, 2025-12-31) — Working Capital: 1421611000.00
PCVX income_statement (quarterly, 2026-03-31) — +Operating Expense: 345850000.00
PCVX income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
PCVX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 63060000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 5478270000.00
PCVX cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -3112000.00
PCVX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 139506680.00
PCVX income_statement (quarterly, 2026-03-31) — Basic EPS: -2.30
PCVX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 175425000.00
PCVX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -14794000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 116297000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 147000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 260843000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1737178000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 171693000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Cash Financial: 89150000.00
PCVX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 601583000.00
PCVX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -233410000.00
PCVX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -280625000.00
PCVX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -269000.00
PCVX cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 39281000.00
PCVX cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -16876000.00
PCVX cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -1285000.00
PCVX cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -15018000.00
PCVX cash_flow (quarterly, 2026-03-31) — Change In Payable: -269000.00
PCVX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 39012000.00
PCVX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -8743000.00
PCVX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -2910000.00
PCVX cash_flow (quarterly, 2026-03-31) — Changes In Cash: 87548000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Common Stock: 147000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2996014000.00
PCVX cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 601846000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 164951000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Current Assets: 1813488000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 6085000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 6085000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 242082000.00
PCVX cash_flow (quarterly, 2026-03-31) — Depreciation: 5854000.00
PCVX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 5854000.00
PCVX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 5854000.00
PCVX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 139506680.00
PCVX income_statement (quarterly, 2026-03-31) — Diluted EPS: -2.30
PCVX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -320622000.00
PCVX income_statement (quarterly, 2026-03-31) — EBIT: -345850000.00
PCVX income_statement (quarterly, 2026-03-31) — EBITDA: -339996000.00
PCVX cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -664000.00
PCVX cash_flow (quarterly, 2026-03-31) — End Cash Position: 262309000.00
PCVX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 601583000.00
PCVX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -295419000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -6834000.00
PCVX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 33071000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 373798000.00
PCVX income_statement (quarterly, 2026-03-31) — Interest Income: 26610000.00
PCVX income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 26610000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2996014000.00
PCVX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -233410000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 1004017000.00
PCVX cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 601846000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 110212000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 110212000.00
PCVX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 601846000.00
PCVX cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 2201000.00
PCVX income_statement (quarterly, 2026-03-31) — Net Income: -320622000.00
PCVX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -320622000.00
PCVX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -320622000.00
PCVX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -320622000.00
PCVX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -320622000.00
PCVX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -320622000.00
PCVX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -320622000.00
PCVX income_statement (quarterly, 2026-03-31) — Net Interest Income: 26610000.00
PCVX cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -218616000.00
PCVX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 26610000.00
PCVX cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -9295000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Net PPE: 373798000.00
PCVX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -14794000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2996014000.00
PCVX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -339996000.00
PCVX income_statement (quarterly, 2026-03-31) — Normalized Income: -320622000.00
PCVX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -280625000.00
PCVX cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 2201000.00
PCVX income_statement (quarterly, 2026-03-31) — Operating Income: -345850000.00
PCVX income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
PCVX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 144314981.00
PCVX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 76310000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -6834000.00
PCVX income_statement (quarterly, 2026-03-31) — Other Gand A: 33071000.00
PCVX income_statement (quarterly, 2026-03-31) — Other Income Expense: -1382000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 157005000.00
PCVX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -1382000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Other Properties: 373798000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 1476335000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Payables: 63060000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 228011000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 7986000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
PCVX income_statement (quarterly, 2026-03-31) — Pretax Income: -320622000.00
PCVX cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 9032000.00
PCVX cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -584129000.00
PCVX cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -14794000.00
PCVX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 5854000.00
PCVX income_statement (quarterly, 2026-03-31) — Research And Development: 312779000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -2475569000.00
PCVX cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 365513000.00
PCVX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 33071000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Share Issued: 144314981.00
PCVX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 37964000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2996014000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2996014000.00
PCVX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
PCVX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
PCVX balance_sheet (quarterly, 2026-03-31) — Total Assets: 3348308000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2996014000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Total Debt: 116297000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2996014000.00
PCVX income_statement (quarterly, 2026-03-31) — Total Expenses: 345850000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 352294000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1534820000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 110212000.00
PCVX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -345850000.00
PCVX balance_sheet (quarterly, 2026-03-31) — Working Capital: 1571406000.00
PCX.DE income_statement (annual, 2022-05-31) — +Operating Expense: 1415400000.00
PCX.DE income_statement (annual, 2022-05-31) — +Total Revenue: 4611700000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Accounts Payable: 105700000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Accounts Receivable: 723800000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Accrued Interest Receivable: 22300000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Accumulated Depreciation: -1055700000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Additional Paid In Capital: 1545900000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Allowance For Doubtful Accounts Receivable: -18200000.00
PCX.DE cash_flow (annual, 2022-05-31) — Amortization Cash Flow: 58100000.00
PCX.DE cash_flow (annual, 2022-05-31) — Amortization Of Intangibles: 58100000.00
PCX.DE cash_flow (annual, 2022-05-31) — Amortization Of Securities: 28900000.00
PCX.DE income_statement (annual, 2022-05-31) — Basic Average Shares: 360600000.00
PCX.DE income_statement (annual, 2022-05-31) — Basic EPS: 3.86
PCX.DE cash_flow (annual, 2022-05-31) — Beginning Cash Position: 1823100000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Buildings And Improvements: 157100000.00
PCX.DE cash_flow (annual, 2022-05-31) — Capital Expenditure: -133800000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Capital Lease Obligations: 74800000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Capital Stock: 3600000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Cash And Cash Equivalents: 370000000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Cash Cash Equivalents And Short Term Investments: 1223900000.00
PCX.DE cash_flow (annual, 2022-05-31) — Cash Dividends Paid: -999600000.00
PCX.DE cash_flow (annual, 2022-05-31) — Cash Flow From Continuing Financing Activities: -979300000.00
PCX.DE cash_flow (annual, 2022-05-31) — Cash Flow From Continuing Investing Activities: -1505100000.00
PCX.DE cash_flow (annual, 2022-05-31) — Cash Flow From Continuing Operating Activities: 1589700000.00
PCX.DE cash_flow (annual, 2022-05-31) — Change In Account Payable: 113100000.00
PCX.DE cash_flow (annual, 2022-05-31) — Change In Other Working Capital: -245100000.00
PCX.DE cash_flow (annual, 2022-05-31) — Change In Payable: 113100000.00
PCX.DE cash_flow (annual, 2022-05-31) — Change In Payables And Accrued Expense: 113100000.00
PCX.DE cash_flow (annual, 2022-05-31) — Change In Prepaid Assets: -7700000.00
PCX.DE cash_flow (annual, 2022-05-31) — Change In Receivables: -152000000.00
PCX.DE cash_flow (annual, 2022-05-31) — Change In Working Capital: -291700000.00
PCX.DE cash_flow (annual, 2022-05-31) — Changes In Account Receivables: -154100000.00
PCX.DE cash_flow (annual, 2022-05-31) — Changes In Cash: -894700000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Common Stock: 3600000.00
PCX.DE cash_flow (annual, 2022-05-31) — Common Stock Dividend Paid: -999600000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Common Stock Equity: 3085200000.00
PCX.DE cash_flow (annual, 2022-05-31) — Common Stock Payments: -145200000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Construction In Progress: 50700000.00
PCX.DE income_statement (annual, 2022-05-31) — Cost Of Revenue: 1356300000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Current Assets: 6581600000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Current Debt: 8700000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Current Debt And Capital Lease Obligation: 8700000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Current Deferred Liabilities: 38400000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Current Deferred Revenue: 38400000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Current Liabilities: 5269200000.00
PCX.DE cash_flow (annual, 2022-05-31) — Deferred Income Tax: 2300000.00
PCX.DE cash_flow (annual, 2022-05-31) — Deferred Tax: 2300000.00
PCX.DE cash_flow (annual, 2022-05-31) — Depreciation: 133700000.00
PCX.DE cash_flow (annual, 2022-05-31) — Depreciation Amortization Depletion: 191800000.00
PCX.DE cash_flow (annual, 2022-05-31) — Depreciation And Amortization: 191800000.00
PCX.DE income_statement (annual, 2022-05-31) — Diluted Average Shares: 363100000.00
PCX.DE income_statement (annual, 2022-05-31) — Diluted EPS: 3.84
PCX.DE income_statement (annual, 2022-05-31) — Diluted NI Availto Com Stockholders: 1392800000.00
PCX.DE income_statement (annual, 2022-05-31) — EBIT: 1861200000.00
PCX.DE income_statement (annual, 2022-05-31) — EBITDA: 2053000000.00
PCX.DE cash_flow (annual, 2022-05-31) — End Cash Position: 928400000.00
PCX.DE cash_flow (annual, 2022-05-31) — Financing Cash Flow: -979300000.00
PCX.DE cash_flow (annual, 2022-05-31) — Free Cash Flow: 1455900000.00
PCX.DE cash_flow (annual, 2022-05-31) — Gain Loss On Investment Securities: -200000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Gains Losses Not Affecting Retained Earnings: -133900000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Goodwill: 1831500000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Goodwill And Other Intangible Assets: 2056100000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Gross Accounts Receivable: 742000000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Gross PPE: 1535700000.00
PCX.DE income_statement (annual, 2022-05-31) — Gross Profit: 3255400000.00
PCX.DE cash_flow (annual, 2022-05-31) — Income Tax Paid Supplemental Data: 397700000.00
PCX.DE income_statement (annual, 2022-05-31) — Interest Expense: 36600000.00
PCX.DE income_statement (annual, 2022-05-31) — Interest Expense Non Operating: 36600000.00
PCX.DE income_statement (annual, 2022-05-31) — Interest Income: 2900000.00
PCX.DE income_statement (annual, 2022-05-31) — Interest Income Non Operating: 2900000.00
PCX.DE cash_flow (annual, 2022-05-31) — Interest Paid Supplemental Data: 35500000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Invested Capital: 3891600000.00
PCX.DE cash_flow (annual, 2022-05-31) — Investing Cash Flow: -1505100000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Investments And Advances: 5000000.00
PCX.DE cash_flow (annual, 2022-05-31) — Issuance Of Debt: 1300000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Land And Improvements: 10300000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Leases: 91700000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Line Of Credit: 8700000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Long Term Capital Lease Obligation: 74800000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Long Term Debt: 797700000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Long Term Debt And Capital Lease Obligation: 872500000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Machinery Furniture Equipment: 929800000.00
PCX.DE cash_flow (annual, 2022-05-31) — Net Business Purchase And Sale: -24900000.00
PCX.DE cash_flow (annual, 2022-05-31) — Net Common Stock Issuance: -145200000.00
PCX.DE balance_sheet (annual, 2022-05-31) — Net Debt: 436400000.00
PCX.DE income_statement (annual, 2022-05-31) — Net Income: 1392800000.00
PCX.DE income_statement (annual, 2022-05-31) — Net Income Common Stockholders: 1392800000.00
PCX.DE income_statement (annual, 2022-05-31) — Net Income Continuous Operations: 1392800000.00
PCX.DE income_statement (annual, 2022-05-31) — Net Income From Continuing And Discontinued Operation: 1392800000.00